We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
101
DraftKings
DKNG
$13B
$18.8M 0.09%
+390,000
New +$20.7M
IPAXU
102
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$18.8M 0.09%
+1,900,000
New +$18.8M
FIVN icon
103
FIVE9
FIVN
$2.45B
$18.5M 0.09%
+116,000
New +$21.2M
RC
104
Ready Capital
RC
$311M
$18M 0.08%
1,250,226
– –
PNT
105
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$17.6M 0.08%
2,290,000
-110,000
-5% -$1M
NVAX icon
106
Novavax
NVAX
$1.47B
$17.4M 0.08%
83,713
+43,713
+109% +$9.63M
FVIV
107
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$17M 0.08%
1,750,000
– –
SEPA
108
DELISTED
SEP Acquisition Corp Class A Common Stock
SEPA
$16.9M 0.08%
+1,732,500
New +$17M
SHQA
109
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
$16M 0.07%
+1,650,000
New +$16M
BSKY
110
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$15.2M 0.07%
+1,550,000
New +$15.1M
SRPT icon
111
Sarepta Therapeutics
SRPT
$1.98B
$15M 0.07%
+162,000
New +$12.5M
KYNB
112
Kyntra Bio
KYNB
$30.4M
$14.8M 0.07%
57,848
+291
+0.5% +$103K
KAHC
113
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$14.6M 0.07%
1,500,000
– –
ASZ
114
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14.6M 0.07%
1,500,000
– –
ZEAL
115
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$14.3M 0.07%
510,000
– –
RCEL icon
116
Avita Medical
RCEL
$311M
$14.2M 0.07%
800,000
– –
DISA
117
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$13.6M 0.06%
1,400,000
– –
AJRD
118
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$12.8M 0.06%
293,000
-252,000
-46% -$11.2M
YMM icon
119
Full Truck Alliance
YMM
$9.1B
$12.5M 0.06%
815,000
+54,251
+7% +$798K
FRXB
120
DELISTED
Forest Road Acquisition Corp. II
FRXB
$12.2M 0.06%
1,250,000
– –
AGGR
121
DELISTED
Agile Growth Corp
AGGR
$11.7M 0.05%
1,200,000
– –
GRND icon
122
Grindr
GRND
$2.7B
$10.9M 0.05%
1,080,000
– –
SOND
123
DELISTED
Sonder
SOND
$10.9M 0.05%
55,000
– –
PRDS
124
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.95M 0.05%
1,000,000
– –
CAS
125
DELISTED
Cascade Acquisition Corp.
CAS
$9.85M 0.05%
990,000
– –
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.